Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ivan Jakovljevic, Djordje Petrovic, Ljubinka Joksovic, Ivan Lazarevic, Milena Jelikic-Stankov & Predrag Djurdjevic. (2015) Complex formation equilibria between aluminum(III), gadolinium(III) and yttrium(III) ions and some fluoroquinolone ligands. Potentiometric and spectroscopic study. Journal of Coordination Chemistry 68:24, pages 4272-4295.
Read now
Read now
Alex N. Eberle & Gabriele Mild. (2009) Receptor-mediated tumor targeting with radiopeptides. Journal of Receptors and Signal Transduction 29:1, pages 1-37.
Read now
Read now
Articles from other publishers (35)
Handan Tokmak. 2022. Radionuclide Therapy. Radionuclide Therapy
377
387
.
Mayra M. Ferrari Barbosa, Alex Issamu Kanno, Leonardo Paiva Farias, Mariusz Madej, Gergö Sipos, Silverio Sbrana, Luigina Romani, Diana Boraschi, Luciana C. C. Leite & Paola Italiani. (2021) Primary and Memory Response of Human Monocytes to Vaccines: Role of Nanoparticulate Antigens in Inducing Innate Memory. Nanomaterials 11:4, pages 931.
Crossref
Crossref
Olga Oleksiienko & Mika Sillanpää. 2020. Advanced Water Treatment. Advanced Water Treatment
361
444
.
Ali Gholamrezanezhad, Hossein Shooli, Narges Jokar, Reza Nemati & Majid Assadi. (2019) Radioimmunotherapy (RIT) in Brain Tumors. Nuclear Medicine and Molecular Imaging 53:6, pages 374-381.
Crossref
Crossref
Cynthia Kassab, Brittany Parker Kerrigan, Hillary Caruso, Sanaalarab Al Enazy & Amy B. Heimberger. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
297
334
.
Zhipeng Liu, Li Xiong, Guoqing Ouyang, Lun Ma, Sunil Sahi, Kunpeng Wang, Liangwu Lin, He Huang, Xiongying Miao, Wei Chen & Yu Wen. (2017) Investigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment. Scientific Reports 7:1.
Crossref
Crossref
Ting-Yu Angela Liao, Alice Lau, Sunil Joseph, Vesa Hytönen & Zakaria Hmama. (2015) Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin System. PLOS ONE 10:12, pages e0145833.
Crossref
Crossref
Yunan YangReinier HernandezJun RaoLi YinYazhuo QuJinrong WuChristopher G. EnglandStephen A. GravesChristina M. LewisPu WangMary E. MeyerandRobert J. NicklesXiu-wu BianWeibo Cai. (2015)
Targeting CD146 with a
64
Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas
. Proceedings of the National Academy of Sciences 112:47.
Crossref
Crossref
Chirag K. Vyas, Pranav M. Joshirao & Vijay K. Manchanda. (2014) Perchloric acid: A promising medium for the chromatographic separation of 90Y from 90Sr. Separation and Purification Technology 124, pages 179-185.
Crossref
Crossref
Pasquale De BonisGiorgio Lofrese, Carmelo Anile, Angelo Pompucci, Vera Vigo & Annunziato Mangiola. (2013) Radioimmunotherapy for high-grade glioma. Immunotherapy 5:6, pages 647-659.
Crossref
Crossref
Baba Issa Camara, Houda Mokrani & Evans Afenya. (2013) Mathematical modeling of glioma therapy using oncolytic viruses. Mathematical Biosciences and Engineering 10:3, pages 565-578.
Crossref
Crossref
Thomas Wirth, Jere Tuomas Pikkarainen, Haritha Dhammika Samaranayake, Pauliina Lehtolainen‐Dalkilic, Hanna Pirita Lesch, Kari Juhani Airenne, Varpu Marjomäki & Seppo Pasi Antero Ylä‐Herttuala. (2012) Efficient gene therapy based targeting system for the treatment of inoperable tumors. The Journal of Gene Medicine 14:4, pages 221-230.
Crossref
Crossref
Gabriele Pöpperl. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
187
198
.
Mirco Bartolomei & Giovanni Paganelli. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
207
214
.
Franklin C. Wong. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
703
715
.
David M. Goldenberg & Robert M. Sharkey. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
125
138
.
Katharina Frey, Michael Fiechter, Kathrin Schwager, Benedetta Belloni, Marjam J. Barysch, Dario Neri & Reinhard Dummer. (2011) Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Experimental Dermatology 20:8, pages 685-688.
Crossref
Crossref
Katharina Frey & Dario Neri. 2011. Tumor-Associated Fibroblasts and their Matrix. Tumor-Associated Fibroblasts and their Matrix
419
450
.
Abmel Xiques Castillo, Marylaine Pérez-Malo, Keila Isaac-Olivé, Heyam Mukhallalati, Edgar Casanova González, Mirta Torres Berdeguez & Néstor Cornejo Díaz. (2010) Production of large quantities of 90Y by ion-exchange chromatography using an organic resin and a chelating agent. Nuclear Medicine and Biology 37:8, pages 935-942.
Crossref
Crossref
M Pedretti, C Verpelli, J Mårlind, G Bertani, C Sala, D Neri & L Bello. (2010) Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma. British Journal of Cancer 103:6, pages 827-836.
Crossref
Crossref
V. P. Baklaushev, K. A. Pavlov & V. P. Chekhonin. (2009) Monoclonal antibodies in diagnostics of high-grade gliomas. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 3:2, pages 105-115.
Crossref
Crossref
Xuhui Zhou, Weiguo Hu & Xuebin Qin. (2008) The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy. The Oncologist 13:9, pages 954-966.
Crossref
Crossref
Juha A. E. Määttä, Tomi T. Airenne, Henri R. Nordlund, Janne Jänis, Tiina A. Paldanius, Pirjo Vainiotalo, Mark S. Johnson, Markku S. Kulomaa & Vesa P. Hytönen. (2008) Rational Modification of Ligand-Binding Preference of Avidin by Circular Permutation and Mutagenesis. ChemBioChem 9:7, pages 1124-1135.
Crossref
Crossref
Usha Pandey, Prem S. Dhami, Poonam Jagesia, Meera Venkatesh & M. R. A. Pillai. (2008)
Extraction Paper Chromatography Technique for the Radionuclidic Purity Evaluation of
90
Y for Clinical Use
. Analytical Chemistry 80:3, pages 801-807.
Crossref
Crossref
Rubel Chakravarty, Usha Pandey, Remani B. Manolkar, Ashutosh Dash, Meera Venkatesh & M.R. Ambikalmajan Pillai. (2008) Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy. Nuclear Medicine and Biology 35:2, pages 245-253.
Crossref
Crossref
Leonel A. Torres, Marco A. Coca, Juan F. Batista, Angel Casaco, Gerardo Lopez, Ivan García, Alejandro Perera, Yamilé Peña, Abel Hernández, Yolaine Sanchez, Susana Romero, Rene Leyva, Anais Prats & Ramses Fernandez. (2008) Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas. Nuclear Medicine Communications 29:1, pages 66-75.
Crossref
Crossref
Paolo Macor, Claudio Tripodo, Sonia Zorzet, Erich Piovan, Fleur Bossi, Roberto Marzari, Alberto Amadori & Francesco Tedesco. (2007)
In vivo
Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab
. Cancer Research 67:21, pages 10556-10563.
Crossref
Crossref
Pier F. Ferrucci, Anna Vanazzi, Chiara M. Grana, Marta Cremonesi, Mirco Bartolomei, Marco Chinol, Mahila Ferrari, Davide Radice, Stefano Papi, Giovanni Martinelli & Giovanni Paganelli. (2007)
High activity
90
Y-ibritumomab tiuxetan (Zevalin
?
) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas
. British Journal of Haematology 139:4, pages 590-599.
Crossref
Crossref
Azizul Haque, Naren L. Banik & Swapan K. Ray. (2007) Emerging Role of Combination of All-trans Retinoic Acid and Interferon-gamma as Chemoimmunotherapy in the Management of Human Glioblastoma. Neurochemical Research 32:12, pages 2203-2209.
Crossref
Crossref
Margaret Cooper. 2007. Advances in Nuclear Oncology:. Advances in Nuclear Oncology:
433
442
.
Giuseppe Palumbo, Chiara M. Grana, Francesca Cocca, Rita De Santis, Domenico Del Principe, Silvia M. Baio, Riccardo Mei & Giovanni Paganelli. (2007) Pretargeted antibody-guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphoma. European Journal of Haematology 79:3, pages 258-262.
Crossref
Crossref
Paolo Macor & Francesco Tedesco. (2007) Complement as effector system in cancer immunotherapy. Immunology Letters 111:1, pages 6-13.
Crossref
Crossref
Olli H. Laitinen, Henri R. Nordlund, Vesa P. Hyt?nen & Markku S. Kulomaa. (2007) Brave new (strept)avidins in biotechnology. Trends in Biotechnology 25:6, pages 269-277.
Crossref
Crossref
D M Goldenberg & R M Sharkey. (2007) Novel radiolabeled antibody conjugates. Oncogene 26:25, pages 3734-3744.
Crossref
Crossref
David M. Goldenberg, Jean-Francois Chatal, Jacques Barbet, Otto Boerman & Robert M. Sharkey. (2007) Cancer imaging and therapy with bispecific antibody pretargeting. Update on Cancer Therapeutics 2:1, pages 19-31.
Crossref
Crossref